Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption
Abstract
:1. Introduction
2. Materials and Methods
2.1. Data
2.2. Methods
2.2.1. Healthcare Cost
2.2.2. Social Care Cost
2.2.3. Law Enforcement Cost
2.2.4. Lost Productivity
2.2.5. Other Types of Cost
2.2.6. Traffic Accident Cost
2.2.7. Cost of Social Care
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Onukwugha, E.; McRae, J.; Kravetz, A.; Varga, S.; Khairnar, R.; Mullins, C.D. Cost-of-Illness Studies: An Updated Review of Current Methods. PharmacoEconomics 2016, 34, 43–58. [Google Scholar] [CrossRef]
- Lozano, R.; Naghavi, M.; Foreman, K.; Lim, S.; Shibuya, K.; Aboyans, V.; Abraham, J.; Adair, T.; Aggarwal, R.; Ahn, S.Y.; et al. Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2095–2128. [Google Scholar] [CrossRef]
- Angelis, A.; Tordrup, D.; Kanavos, P. Socio-Economic Burden of Rare Diseases: A Systematic Review of Cost of Illness Evidence. Health Policy 2015, 119, 964–979. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Mangen, M.-J.J.; Bouwknegt, M.; Friesema, I.H.M.; Haagsma, J.A.; Kortbeek, L.M.; Tariq, L.; Wilson, M.; van Pelt, W.; Havelaar, A.H. Cost-of-Illness and Disease Burden of Food-Related Pathogens in the Netherlands, 2011. Int. J. Food Microbiol. 2015, 196, 84–93. [Google Scholar] [CrossRef]
- Gabbe, B.J.; Lyons, R.A.; Fitzgerald, M.C.; Judson, R.; Richardson, J.; Cameron, P.A. Reduced Population Burden of Road Transport-Related Major Trauma after Introduction of an Inclusive Trauma System. Ann. Surg. 2015, 261, 565–572. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Jo, C. Cost-of-Illness Studies: Concepts, Scopes, and Methods. Clin. Mol. Hepatol. 2014, 20, 327–337. [Google Scholar] [CrossRef]
- Jarl, J.; Gerdtham, U.-G.; Ludbrook, A.; Petrie, D. On Measurement of Avoidable and Unavoidable Cost of Alcohol: An Application of Method for Estimating Costs Due to Prior Consumption. Int. J. Environ. Res. Public Health 2010, 7, 2881–2895. [Google Scholar] [CrossRef][Green Version]
- Currie, G.; Kerfoot, K.D.; Donaldson, C.; Macarthur, C. Are Cost of Injury Studies Useful? Inj. Prev. 2000, 6. [Google Scholar] [CrossRef][Green Version]
- Farnham, P.G. Defining and Measuring the Costs of the HIV Epidemic to Business Firms. Public Health Rep. 1994, 109, 311–318. [Google Scholar] [PubMed]
- Anders, B.; Ommen, O.; Pfaff, H.; Lüngen, M.; Lefering, R.; Thüm, S.; Janssen, C. Direct, Indirect, and Intangible Costs after Severe Trauma up to Occupational Reintegration—An Empirical Analysis of 113 Seriously Injured Patients. Psycho-Soc. Med. 2013, 10, Doc02. [Google Scholar] [CrossRef]
- Single, E.; Collins, D.; Easton, B.; Harwood, H.; Lapsley, H.; Kopp, P.; Wilson, E. International Guidelines for Estimating the Costs of Substance Abuse, 2nd ed.; WHO Publications: Geneva, Switzerland, 2003. [Google Scholar]
- Tajima-Pozo, K.; de Castro Oller, M.J.; Lewczuk, A.; Montañes-Rada, F. Understanding the Direct and Indirect Costs of Patients with Schizophrenia. F1000 Res. 2015, 4, 182. [Google Scholar] [CrossRef]
- Thavorncharoensap, M.; Teerawattananon, Y.; Yothasamut, J.; Lertpitakpong, C.; Chaikledkaew, U. The Economic Impact of Alcohol Consumption: A Systematic Review. Subst. Abus. Treat. Prev. Policy 2009, 4, 1–11. [Google Scholar] [CrossRef][Green Version]
- Um, M.J.; Kwak, S.J.; Kim, T.Y. Estimating Willingness to Pay for Improved Drinking Water Quality Using Averting Behavior Method with Perception Measure. Environ. Resour. Econ. 2002, 21, 287–302. [Google Scholar] [CrossRef]
- French, M.T.; Rachal, J.V.; Hubbard, R.L. Conceptual Framework for Estimating the Social Cost of Drug Abuse. J. Health Soc. Policy 1991, 2, 1–22. [Google Scholar] [CrossRef] [PubMed]
- Gold, M.R.; Stevenson, D.; Fryback, D.G. HALYS and QALYS and DALYS, Oh My: Similarities and Differences in Summary Measures of Population Health. Annu. Rev. Public Health 2002, 23, 115–134. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Ippolito, P.M.; Ippolito, R.A. Measuring the Value of Life Saving from Consumer Reactions to New Information. J. Public Econ. 1984, 25, 53–81. [Google Scholar] [CrossRef]
- Rothermich, E.A.; Pathak, D.S. Productivity-Cost Controversies in Cost-Effectiveness Analysis: Review and Research Agenda. Clin. Ther. 1999, 21, 255–267. [Google Scholar] [CrossRef]
- Kishore, G.S.; Kuriachan, M.A.; Subash, P. Pharmacoeconomics: Cost of Illness Studies. Hygeia 2009, 1, 46–49. [Google Scholar]
- Koopmanschap, M.A.; Rutten, F.F.H.; van Ineveld, B.M.; van Roijen, L. The Friction Cost Method for Measuring Indirect Costs of Disease. J. Health Econ. 1995, 14, 171–189. [Google Scholar] [CrossRef]
- Brouwer, W.B.F.; Koopmanschap, M.A. The Friction-Cost Method: Replacement for Nothing and Leisure for Free? PharmacoEconomics 2005, 23, 105–111. [Google Scholar] [CrossRef]
- Jarl, J. The Societal Burden of Alcohol Misuse: Literature Review and Cost of Alcohol Related Hospitalisation in Skane, Sweden—2003; Lunds University: Lunds, Sweden, 2005. [Google Scholar]
- Le, T.; Gibson, J.; Oxley, L. Cost- and Income-Based Measures of Human Capital. J. Econ. Surv. 2003, 17, 271–307. [Google Scholar] [CrossRef]
- Hodgson, T.A.; Meiners, M.R. Cost-of-Illness Methodology: A Guide to Current Practices and Procedures. Milbank Meml. Fund Q. Health Soc. 1982, 60, 429–462. [Google Scholar] [CrossRef][Green Version]
- Dickie, M. Averting Behavior Methods. In A Primer on Nonmarket Valuation; Springer: Dordrecht, The Netherlands, 2017; pp. 293–346. ISBN 978-94-007-7103-1. [Google Scholar]
- Breidert, C.; Hahsler, M.; Reutterer, T. A Review of Methods for Measuring Willingness-to-Pay. Innov. Mark. 2006, 2, 8–32. [Google Scholar]
- Cookson, R. Willingness to Pay Methods in Health Care: A Sceptical View. Health Econ. 2003, 12, 891–894. [Google Scholar] [CrossRef]
- Gafni, A. Willingness to Pay in the Context of an Economic Evaluation of Healthcare Programs: Theory and Practice. Am. J. Manag. Care 1997, 3, S21–S32. [Google Scholar]
- Pagano, E.; Brunetti, M.; Tediosi, F.; Garattini, L. Costs of Diabetes. PharmacoEconomics 1999, 15, 583–595. [Google Scholar] [CrossRef] [PubMed]
- Pike, J.; Grosse, S.D. Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review. Appl. Health Econ. Health Policy 2018, 16, 765–778. [Google Scholar] [CrossRef] [PubMed]
- Rice, D.P. Cost of Illness Studies: What Is Good about Them? Inj. Prev. 2000, 6, 177–179. [Google Scholar] [CrossRef][Green Version]
- Fenoglio, P.; Parel, V.; Kopp, P. The Social Cost of Alcohol, Tobacco and Illicit Drugs in France, 1997. Eur. Addict. Res. 2003, 9, 18–28. [Google Scholar] [CrossRef]
- Petrie, D.; Doran, C.; Shakeshaft, A. Willingness to Pay to Reduce Alcohol-Related Harm in Australian Rural Communities. Expert Rev. Pharm. Outcomes Res. 2011, 11, 351–363. [Google Scholar] [CrossRef]
- Konnopka, A.; Koenig, H.-H. Direct and Indirect Costs Attributable to Alcohol Consumption in Germany. PharmacoEconomics 2007, 25, 605–618. [Google Scholar] [CrossRef]
- Chan, B.; Cadarette, S.; Wodchis, W.; Wong, J.; Mittmann, N.; Krahn, M. Cost-of-Illness Studies in Chronic Ulcers: A Systematic Review. J. Wound Care 2017, 26, S4–S14. [Google Scholar] [CrossRef][Green Version]
- Razzouk, D. Burden and indirect costs of mental disorders. In Mental Health Economics: The Costs and Benefits of Psychiatric Care; Springer International Publishing: Cham, Switzerland, 2017; pp. 381–391. ISBN 978-3-319-55266-8. [Google Scholar]
- Zabransky, T.; Belackova, V.; Stefunkova, M.; Vopravil, J.; Langrova, M. Společenské Náklady Užívání Alkoholu, Tabáku a Nelegálních Drog v ČR v Roce 2007, 1st ed.; Centrum adiktologie PK 1.LF UK v Praze: Praha, Czech Republic, 2011; ISBN 978-80-260-1680-9. [Google Scholar]
- Mlčoch, T.; Chadimová, K.; Doležal, T.; Dolejší, D.; Hájíčková, B.; Mazalová, M.; Lamblová, K. Společenské Náklady Konzumace Alkoholu v České Republice; IHETA Autorský Kolektiv: Prague, Czech Republic, 2019. [Google Scholar]
- Ramstedt, M. What Drug Policies Cost: Estimating Drug Policy Expenditures in Sweden, 2002. Addiction 2006, 101, 330–338. [Google Scholar] [CrossRef] [PubMed]
- Rozpočet Ministertva Vnitra—Záverečný Účet Kapitoly 314; Ministry of Internal Affairs: Prague, Czech Republic, 2018.
- Záverečný Účet Kapitoly 336; Ministry of Justice: Prague, Czech Republic, 2018.
- Statistika Probační a Mediační Služby 2017; Probation and Meditaion Service: Prague, Czech Republic, 2018.
- Výroční Zpráva Finanční Správy 2017; Finance Administration: Prague, Czech Republic, 2018.
- Nigel Babu, Massachusetts Institute of Technology. Salary Converter. Available online: http://salaryconverter.nigelb.me/ (accessed on 23 April 2021).
- World Bank. PPP Conversion Factor, Private Consumption (LCU per International $). Available online: https://data.worldbank.org/indicator/PA.NUS.PRVT.PP (accessed on 23 April 2021).
- Møller, L.; Matic, S. Best Practice in Estimating the Costs of Alcohol-Recommendations for Future Studies; WHO Regional Office for Europe: Copenhagen, Denmark, 2010; ISBN 978-92-890-4207-9. [Google Scholar]
- Rockhill, B.; Newman, B.; Weinberg, C. Use and Misuse of Population Attributable Fractions. Am. J. Public Health 1998, 88, 15–19. [Google Scholar] [CrossRef][Green Version]
- Patra, J.; Taylor, B.; Rehm, J.T.; Baliunas, D.; Popova, S. Substance-Attributable Morbidity and Mortality Changes to Canada’s Epidemiological Profile: Measurable Differences over a Ten-Year Period. Can. J. Public Health 2007, 98, 228–234. [Google Scholar] [CrossRef] [PubMed]
- Collins, D.J.; Lapsley, H.M. Counting the Cost: Estimates of the Social Costs of Drug Abuse in Australia in 1998-9; Commonwealth Department of Health and Ageing: Canbera, Australia, 2002.
- Shield, K.; Parry, C.; Rehm, J. Chronic Diseases and Conditions Related to Alcohol Use. Alcohol Res. 2013, 35, 155–173. [Google Scholar] [PubMed]
- Rehm, J.; Baliunas, D.; Borges, G.L.G.; Graham, K.; Irving, H.; Kehoe, T.; Parry, C.D.; Patra, J.; Popova, S.; Poznyak, V.; et al. The Relation between Different Dimensions of Alcohol Consumption and Burden of Disease: An Overview. Addiction 2010, 105, 817–843. [Google Scholar] [CrossRef][Green Version]
- Webster, L.; Angus, C.; Holmes, J.; Brennan, A.; Gillespie, D. Alcohol Attributable Fractions for England; University of Sheffield: Sheffield, UK, 2019. [Google Scholar]
- Jones, L.; Bellis, M.A. Updating England-Specific Alcohol-Attributable Fractions; Liverpool John Moores University: Liverpool, UK, 2013. [Google Scholar]
- Bloom, B.S.; Bruno, D.J.; Maman, D.Y.; Jayadevappa, R. Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making. PharmacoEconomics 2001, 19, 207–213. [Google Scholar] [CrossRef] [PubMed]
- Sutton, I. Frequency Analysis. In Process Risk and Reliability Management; Elsevier: Amsterdam, The Netherlands, 2015; pp. 602–666. [Google Scholar]
- Statistické Přehledy Kriminality Za Rok 2017—Policie České Republiky; Police of the Czech Republic: Prague, Czech Republic, 2018.
- Czech Stastistical Office Statistics. Available online: https://vdb.czso.cz/vdbvo2/faces/en/index.jsf?page=vystup-objekt&pvokc=&katalog=30852&pvo=MZDD01-G&z=T#katalog=30832 (accessed on 23 April 2021).
- Zprávy o Činnosti Finanční a Celní Správy—Daňové a Celní Statistiky; Ministry of Finance: Prague, Czech Republic, 2018.
- Statistika Nehodovosti—Policie Českej Republiky; Police of the Czech Republic: Prague, Czech Republic, 2017.
- Statistická Ročenka Hasičského Záchranného Sboru ČR; Fire and Rescue Service: Prague, Czech Republic, 2018.
- Sociální Služby; Czech Social Security Administration: Prague, Czech Republic, 2021.
- Sorge, J.; Young, M.; Maloney-Hall, B.; Sherk, A.; Kent, P.; Zhao, J.; Stockwell, T.; Perlova, K.; Macdonald, S.; Ferguson, B. Estimation of the Impacts of Substance Use on Workplace Productivity: A Hybrid Human Capital and Prevalence-Based Approach Applied to Canada. Can. J. Public Health 2019, 111. [Google Scholar] [CrossRef]
- Varney, S.J.; Guest, J.F. The Annual Societal Cost of Alcohol Misuse in Scotland. PharmacoEconomics 2002, 20, 891–907. [Google Scholar] [CrossRef]
- Chikritzhs, T.; Stockwell, T.; Naimi, T.; Andreasson, S.; Dangardt, F.; Liang, W. Has the Leaning Tower of Presumed Health Benefits from “moderate” Alcohol Use Finally Collapsed? Addiction 2015, 110, 726–727. [Google Scholar] [CrossRef]
- Sherk, A.; Gilmore, W.; Churchill, S.; Lensvelt, E.; Stockwell, T.; Chikritzhs, T. Implications of Cardioprotective Assumptions for National Drinking Guidelines and Alcohol Harm Monitoring Systems. Int. J. Environ. Res. Public Health 2019, 16, 4956. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Sacks, J.J.; Gonzales, K.R.; Bouchery, E.E.; Tomedi, L.E.; Brewer, R.D. 2010 National and State Costs of Excessive Alcohol Consumption. Am. J. Prev. Med. 2015, 49, e73–e79. [Google Scholar] [CrossRef] [PubMed]
- Miller, T.R.; Nygaard, P.; Gaidus, A.; Grube, J.W.; Ponicki, W.R.; Lawrence, B.A.; Gruenewald, P.J. Heterogeneous Costs of Alcohol and Drug Problems Across Cities and Counties in California. Alcohol. Clin. Exp. Res. 2017, 41, 758–768. [Google Scholar] [CrossRef]
- Orosová, O.; Gajdošová, B.; Bačíková-Šléšková, M.; Benka, J.; Bavoľár, J. Alcohol Consumption among Slovak Schoolchildren: Evaluation of the Effectiveness of the Unplugged Programme. Adiktologie 2020, 20, 89–96. [Google Scholar] [CrossRef]
- Horáková, M.; Bejtkovský, J.; Barešová, P.; Urbánek, T. Alcohol Consumption among the Member States of the European Union in Relationship to Taxation. Adiktologie 2020, 20, 47–56. [Google Scholar] [CrossRef]
- Rolová, G. Health Literacy in Residential Addiction Treatment Programs: Study Protocol of a Cross-Sectional Study in People with Substance Use Disorders. Adiktologie 2020, 20, 145–150. [Google Scholar] [CrossRef]
ICD-10 Code | ICD-10 Diagnosis Name | AF | References |
---|---|---|---|
E24.4 | Alcohol-induced pseudo-Cushing syndrome | 1 | by def., [38,51,53] |
F10 | Mental and behavioral disorders due to use of alcohol | 1 | by def., [37,38,48,49,50,51,52,53] |
G31.2 | Degeneration of nervous system due to alcohol | 1 | by def., [38,48,50,51,52,53] |
G62.1 | Alcoholic polyneuropathy | 1 | by def., [38,48,49,50,51,52,53] |
G72.1 | Alcoholic myopathy | 1 | by def., [38,50,51,52,53] |
I42.6 | Alcoholic cardiomyopathy | 1 | by def., [38,48,50,51,52,53] |
K29.2 | Alcoholic gastritis | 1 | by def., [48,49,50,51,52,53] |
K70 | Alcoholic liver disease | 1 | by def., [38,49,50,51,52,53] |
K73 | Chronic hepatitis, not classified elsewhere | 1 | by def., [38,52] |
K85.2 | Alcohol-induced acute pancreatitis | 1 | by def., [38,50,51,52] |
K86.0 | Alcohol-induced chronic pancreatitis | 1 | by def., [48,50,51,52,53] |
O35.4 | Maternal care for (suspected) damage to fetus from alcohol | 1 | by def., [38,48,51,52] |
P04.3 | Fetus and new-born affected by maternal use of alcohol | 1 | by def., [38,50,51] |
Q86.0 | Fetal alcohol syndrome (dysmorphic) | 1 | by def., [38,50,51,53] |
R78.0 | Finding of alcohol in blood | 1 | by def., [38,48,51,52,53] |
T51 | Toxic effect of alcohol | 1 | by def., [51,52] |
X65 | Intentional self-poisoning by and exposure to alcohol | 1 | by def., [49,51,52] |
Y15 | Poisoning by and exposure to alcohol, undetermined intent | 1 | by def., [48,51,52] |
Y90 | Evidence of alcohol involvement determined by blood alcohol level | 1 | by def., [51,52,53] |
X45 | Accidental poisoning by and exposure to alcohol | 1 | by def., [48,52] |
ICD-10 Code | ICD-10 Name | AF Women | AF Men | References |
---|---|---|---|---|
A15–A19 | Tuberculosis | 0.12 | 0.209 | [51,52,53] |
C00–C06 | Malignant neoplasms of lip, tongue, unspecified parts of tongue, gum, floor of mouth, palate, other and unspecified parts of mouth | 0.176 | 0.614 | [37,38,48,49,50,51,52,53] |
C07,C08 | Malignant neoplasms of parotid gland and other unspecified major salivary glands | 0.176 | 0.614 | [37,48,50,51,52,53] |
C09,C10 | Malignant neoplasms of tonsil, oropharynx | 0.176 | 0.614 | [37,38,48,49,50,51,52,53] |
C11 | Malignant neoplasms of nasopharynx | 0.176 | 0.614 | [37,48,50,53] |
C12–C14 | Malignant neoplasms pirifrom sinus, hypopharynx and of other and ill-defined sites in the lip, oral cavity, and pharynx | 0.176 | 0.614 | [37,38,48,49,50,51,52,53] |
C15 | Malignant neoplasm of esophagus | 0.197 | 0.591 | [37,38,48,49,50,51,52,53] |
C16 | Malignant neoplasm of stomach | 0.068 | 0.192 | [37] |
C18 | Malignant neoplasm of colon | 0.17 | 0.17 | [38,50,52,53] |
C19 | Malignant neoplasm of rectosimoid junction | 0.17 | 0.17 | [38,50,52] |
C20 | Malignant neoplasm of rectum | 0.17 | 0.17 | [38,50,52,53] |
C21 | Malignant neoplasm of anus and anal canal | - | 0.17 | [38] |
C22 | Malignant neoplasm of liver and intrahepatic bile ducts | 0.145 | 0.538 | [37,38,48,49,50,51,52,53] |
C25 | Malignant neoplasm of pancreas | 0.013 | 0.022 | [52] |
C32 | Malignant neoplasm of larynx | 0.221 | 0.655 | [37,38,48,49,50,51,52,53] |
C50 | Malignant neoplasm of breast | 0.15 | - | [37,38,48,49,50,52,53] |
C61 | Malignant neoplasm of prostate | 0.17 | - | [38] |
D00–D09 | In situ neoplasms | 0.037 | 0.199 | [37,48,50] |
D10–D36 | Benign neoplasms | 0.037 | 0.199 | [37,48,50] |
D37–D48 | Neoplasms of uncertain or unknown behavior | 0.037 | 0.199 | [37,48,50] |
G40 | Epilepsy | 0.238 | 0.747 | [37,48,49,50,53] |
G41 | Status epilepticus | 0.238 | 0.747 | [37,48,49,50,53] |
I10–I15 | Hypertensive diseases | 0.29 | 0.3 | [37,38,48,49,52,53] |
I47 | Paroxysmal tachycardia | 0.114 | 0.372 | [37,38,48,49,51,52,53] |
I48 | Atrial fibrillation and flutter | 0.114 | 0.372 | [37,38,48,49,50,52,53] |
I49 | Other cardiac arrhythmias | 0.114 | 0.372 | [37,48,51,53] |
I60–I62 | Subarachnoid hemorrhage, intracerebral hemorrhage, other nontraumatic intracranial hemorrhage | - | 0.05 | [37,48,49,51,52,53] |
I63–I66 | Cerebral infarction, stroke, not specified as hemorrhage or infarction, occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction, occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction | - | 0.174 | [37,48,49,50,51,52,53] |
I67–I69 | Other cerebrovascular diseases, cerebrovascular disorders in diseases classified elsewhere, sequelae of cerebrovascular disease | 0.015 | 0.056 | [37,48,49] |
I85 | Esophageal varices | 0.277 | 0.821 | [37,48,49,53] |
J10–J18 | Influenza and pneumonia | 0.031 | 0.062 | [51,52] |
K22.6 | Gastro-esophageal laceration–hemorrhage syndrome | 0.41 | 0.41 | [49] |
K74.3 | Primary biliary cirrhosis | 0.57 | 0.57 | [38,48,51] |
K74.4 | Secondary biliary cirrhosis | 0.57 | 0.57 | [38,48,51] |
K74.5 | Biliary cirrhosis, unspecified | 0.4 | 0.4 | [38,48,51] |
K74.6 | Other and unspecified cirrhosis of liver | 0.4 | 0.4 | [38,48,51] |
K76.6 | Portal hypertension | 0.4 | 0.4 | [38,48,51] |
L40 | Psoriasis | 0.351 | 0.351 | [37,38,48] |
O03 | Spontaneous abortion | 0.015 | - | [37,38,51] |
P05 | Slow fetal growth and fetal malnutrition | 0.017 | - | [37,48,51] |
R96–R99 | Other sudden death, cause unknown, unattended death, other ill-defined and unspecified causes of mortality | 0.1 | 0.1 | [52] |
W00–W19 | Falls | 0.047 | 0.047 | [48,49,52,53] |
X00–X09 | Exposure to smoke, fire, and flames | 0.041 | 0.041 | [48,49,52,53] |
X41 | Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-parkinsonism, and psychotropic drugs, not elsewhere classified | 0.154 | 0.154 | [48,52,53] |
X42 | Accidental poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not classified elsewhere | 0.154 | 0.154 | [48,52,53] |
V01–V99 | Transport accidents | 0.041 | 0.03 | [37,49,52] |
W20–X59 | Other external causes of accidental injury | 0.03 | 0.03 | [48,52] |
X60–X84 | Intentional self-harm | 0.153 | 0.041 | [37,48,49,52,53] |
X85–Y09 | Assault | 0.041 | 0.041 | [48,49,52] |
Y10–Y34 | Event of undetermined intent | 0.041 | 0.041 | [52] |
Y40–Y84 | Complications of medical and surgical care | 0.041 | 0.041 | [52] |
Y85–Y89 | Sequelae of external causes of morbidity and mortality | 0.041 | 0.041 | [52] |
Y90–Y98 | Supplementary factors related to causes of morbidity and mortality classified elsewhere | 0.041 | 0.041 | [52] |
Type of Social Services | Attributable Fraction |
---|---|
Aftercare service | 0.75 |
Therapeutic communities | 0.22 |
Home with special regime | 0.86 |
Professional social counselling | 0.28 |
Contact center | 0.07 |
Field programs | 0.05 |
Healthcare Type | Cost (Million USD-PPP) | Men (%) | Women (%) |
---|---|---|---|
Hospital | 464.05 | 67.24 | 32.76 |
Ambulance | 63.15 | 48.76 | 51.24 |
Total cost (million USD) | 527.21 |
ICD-10 Code | ICD-10 Chapter | Cost (Thousand USD-PPP) | Cost (%) |
---|---|---|---|
A00–B99 | Certain infectious and parasitic diseases | 263.6 | 0.05 |
C00–D48 | Neoplasms | 61,177.06 | 11.60 |
E00–E90 | Endocrine, nutritional, and metabolic diseases | - | - |
F00–F99 | Mental and behavioral disorders | 34,711.29 | 6.58 |
G00–G99 | Diseases of the nervous system | 33,762.32 | 6.40 |
I00–I99 | Diseases of the circulatory system | 321,775.33 | 61.03 |
J00–J99 | Diseases of the respiratory system | 9985.3 | 1.89 |
K00–K93 | Diseases of the digestive system | 34,184.08 | 6.48 |
L00–L99 | Diseases of the skin and subcutaneous tissue | 8034.63 | 1.52 |
O00–O99 | Pregnancy, childbirth, and the puerperium | 1739.78 | 0.33 |
P00–P96 | Certain conditions originating in the perinatal period | 7707.76 | 1.46 |
Q00–Q99 | Congenital malformations, deformations, and chromosomal abnormalities | - | - |
R00–R99 | Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified | 158.16 | 0.03 |
S00–T98 | Injury, poisoning and certain other consequences of external causes | 843.53 | 0.16 |
V01–X59 | Accidents | 8804.35 | 1.67 |
X60–X84 | Intentional self-harm | 210.88 | 0.04 |
X85–Y09 | Assault | 316.32 | 0.06 |
Y10–Y34 | Event of undetermined intent | 263.6 | 0.05 |
Y40–Y84 | Complications of medical and surgical care | 3005.08 | 0.57 |
Y85–Y89 | Sequelae of external causes of morbidity and mortality | - | - |
Y90–Y98 | Supplementary factors related to causes of morbidity and mortality classified elsewhere | 263.6 | 0.05 |
Total healthcare cost | 527,206.67 | 100 |
Cost Type | Cost (Million USD-PPP) | Share (%) | ||
---|---|---|---|---|
I Type * | II Type ** | III Type *** | ||
Disability pension | 79.43 | 22.34 | 15.12 | 62.53 |
Sickness benefit | 22.19 | - | ||
Total cost (million USD) | 101.63 |
ICD-10 Code | ICD-10 Chapter | Cost (Thousand USD-PPP) | Cost (%) |
---|---|---|---|
A00–B99 | Certain infectious and parasitic diseases | 102.09 | 0.46 |
C00–D48 | Neoplasms | 6981.89 | 31.46 |
F00–F99 | Mental and behavioral disorders | 3652.95 | 16.46 |
G00–G99 | Diseases of the nervous system | 1600.11 | 7.21 |
I00–I99 | Diseases of the circulatory system | 6813.23 | 30.70 |
J00–J99 | Diseases of the respiratory system | 545.95 | 2.46 |
K00–K93 | Diseases of the digestive system | 1981.83 | 8.93 |
L00–L99 | Diseases of the skin and subcutaneous tissue | 481.59 | 2.17 |
O00–O99 | Pregnancy, childbirth, and the puerperium | 6.66 | 0.03 |
R00–R99 | Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified | 4.44 | 0.02 |
S00–T98 | Injury, poisoning, and certain other consequences of external causes | 6.66 | 0.03 |
V00–V99 | Accidents | 2.22 | 0.01 |
W00–X59 | Other external causes of accidental injury | 11.1 | 0.05 |
Y10–Y34 | Event of undetermined intent | 2.22 | 0.01 |
Y00–Y09 | Assault | 0.02 | <0.01 |
Total social care cost—sickness benefit | 22,192.96 | 100 |
ICD-10 Code | ICD-10 Chapter | Cost (Thousand USD-PPP) | Cost (%) |
---|---|---|---|
A00–B99 | Certain infectious and parasitic diseases | 262.13 | 0.33 |
C00–D48 | Neoplasms | 23,257.74 | 29.28 |
F00–F99 | Mental and behavioral disorders | 15,759.34 | 19.84 |
G00–G99 | Diseases of the nervous system | 15,171,54 | 19.10 |
I00–I99 | Diseases of the circulatory system | 8308.61 | 10.46 |
J00–J99 | Diseases of the respiratory system | 23.83 | 0.03 |
K00–K93 | Diseases of the digestive system | 12,820.35 | 16.14 |
L00–L99 | Diseases of the skin and subcutaneous tissue | 3828.63 | 4.82 |
Total social care cost—disability pension | 79,432.17 | 100 |
Cost Type | Cost Related to Alcohol (Million USD-PPP) | Cost Related to Alcohol (%) |
---|---|---|
Police | 223.38 | 77.50 |
Public prosecutor’s office | 26.02 | 9.03 |
Courts | 34.12 | 11.84 |
Criminal activity damage | 4.7 | 1.63 |
Total cost (million USD) | 288.21 | - |
Lost Productivity | Morbidity | Mortality |
---|---|---|
Lost productivity (million USD) in PPP | 272.31 | 990.7 |
Commodity | Count | Leakage ED, VAT, Duty (Thousand USD-PPP) | Leakage (%) | Value (Million USD) |
---|---|---|---|---|
Alcohol | 16 | 2104.37 | 94.95 | - |
Spirits | 485 | 107.87 | 4.87 | - |
Fruit distillate | 2 | 0.25 | 0.01 | - |
Beer | 27 | 2.89 | 0.13 | - |
Still wine | 22 | 0.78 | 0.04 | - |
Sparkling wine | 6 | 0.05 | <0.01 | - |
Audits | 55 | - | - | 12.4 |
Audits + leakage | - | - | - | 14.6 |
Traffic Accident | Number of Accidents | Number of Persons |
---|---|---|
With death | 48 | 48 deaths |
With severe injury | 183 | 203 severely injured |
With slight injury | 1441 | 1850 slightly injured |
With material damage | 2579 | - |
Total accident damage in million USD | 20.07 | - |
Cost Type | Cost (Million USD-PPP) | Cost (%) |
---|---|---|
Fire damage attributable to alcohol | 2.56 | 28.06 |
Personal cost of fire and rescue service attributable to alcohol | 6.56 | 71.94 |
Total cost of fire and rescue brigade attributable to alcohol | 9.12 | 100 |
Social Service Type | Cost (Thousand USD-PPP) | Cost (%) |
---|---|---|
Aftercare service | 2126.66 | 2.21 |
Therapeutic communities | 506.34 | 0.53 |
Home with special regime | 85,383.11 | 88.58 |
Professional social counselling | 7449.84 | 7.73 |
Contact center | 286.54 | 0.30 |
Field programs | 642.23 | 0.67 |
Total cost of social care in thousand USD | 96,394.73 | - |
Cost Type | Cost (Million USD-PPP) | Cost (%) |
---|---|---|
Healthcare | 527.21 | 22.71 |
Social care | 101.63 | 4.38 |
Law enforcement | 288.21 | 12.4 |
Lost productivity | 1263.71 | 54.45 |
Financial Administration | 14.6 | 0.63 |
Traffic accidents | 20.07 | 0.86 |
Fire and Rescue brigade | 9.12 | 0.39 |
Social services | 96.39 | 4.16 |
Total cost | 2320.97 | 100 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gavurova, B.; Tarhanicova, M. Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption. Int. J. Environ. Res. Public Health 2021, 18, 4964. https://doi.org/10.3390/ijerph18094964
Gavurova B, Tarhanicova M. Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption. International Journal of Environmental Research and Public Health. 2021; 18(9):4964. https://doi.org/10.3390/ijerph18094964
Chicago/Turabian StyleGavurova, Beata, and Miriama Tarhanicova. 2021. "Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption" International Journal of Environmental Research and Public Health 18, no. 9: 4964. https://doi.org/10.3390/ijerph18094964